| 000 | 01483cam a2200277 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030816.0 | ||
| 008 | 130331s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2011.Ma.D | ||
| 100 | 0 | _aMai Ahmed Hassan Rady | |
| 245 | 1 | 0 |
_aDesign and evaluation of ocular inserts containing timolol maleate / _cMai Ahmed Hassan Rady ; Supervised Mohamed Ali Attia Shafie |
| 246 | 1 | 5 | _aتصميم وتقييم رقائق العين المحتوية على التيمولول ماليت |
| 260 |
_aCairo : _bMai Ahmed Hassan Rady , _c2011 |
||
| 300 |
_a117Leaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Technology | ||
| 520 | _aGlaucoma is the leading cause of irreversible blindness in the world . Ocular drug delivery is one of the most fascinating and challenging tasks facing the pharmaceutical researchers . The poor bioavailability and therapeutic response exhibited by conventional ophthalmic solutions due to rapid precorneal elimination of the drug, this include the blinking reflex tear turnover and low corneal permeability | ||
| 700 | 0 |
_aMohamed Ali Attia Shafie , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42372 _d42372 |
||